Inhibitor of group IIA, IIE, and X forms of sPLA2
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

LY315920

Item No. 18267

Technical Information
Formal Name
2-[[3-(2-amino-2-oxoacetyl)-2-ethyl-1-(phenylmethyl)-1H-indol-4-yl]oxy]-acetic acid
CAS Number
172732-68-2
Synonyms
  • ​Varespladib
Molecular Formula
C21H20N2O5
Formula Weight
Purity
≥95%
Formulation
A crystalline solid
DMF: 2 mg/mlDMSO: 3 mg/mlDMSO:PBS (pH 7.2) (1:1): 0.5 mg/ml
λmax
217, 256, 331 nm
SMILES
O=C(O)COC1=C2C(N(CC3=CC=CC=C3)C(CC)=C2C(C(N)=O)=O)=CC=C1
InChi Code
InChI=1S/C21H20N2O5/c1-2-14-19(20(26)21(22)27)18-15(9-6-10-16(18)28-12-17(24)25)23(14)11-13-7-4-3-5-8-13/h3-10H,2,11-12H2,1H3,(H2,22,27)(H,24,25)
InChi Key
BHLXTPHDSZUFHR-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Lipid Resource Center
    Discover Products & Resources for Lipid Research
    • High-purity lipid standards
    • Lipid roles in biology
    • Lipids in health & disease
    • Lipids for pharmaceutical development
    • Protocols, advice, & resources
    EXPLORE NOW
    Product Description

    LY315920 is an inhibitor of human group IIA (hGIIA) secretory phospholipase A2 (sPLA2; IC50 = 9 nM).1 It also potently inhibits human GIIE and GX isoforms, as well as the corresponding mouse isoforms, but poorly inhibits other PLA2 enzymes.1,2,3,4 LY315920 inhibits sPLA2-induced release of thromboxane A2 from isolated guinea pig lung bronchoalveolar lavage cells (IC50 = 0.79 µM).2 Intravenous or oral administration of LY315920 to transgenic mice expressing human sPLA2 inhibits serum sPLA2 activity in a dose-related manner over four hours.2

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Draheim, S.E., Bach, N.J., Dillard, R.D., et alIndole inhibitors of human nonpancreatic secretory phospholipase A2. 3. Indole-3-glyoxamides. J. Med. Chem. 39(26), 5159-5175 (1996).

    2. Snyder, D.W., Bach, N.J., Dillard, R.D., et alPharmacology of LY315920/S-5920, [[3-(aminooxoacetyl)-2-ethyl-1-(phenylmethyl)-1H-indol-4-yl]oxy] acetate, a potent and selective secretory phospholipase A2 inhibitor: A new class of anti-inflammatory drugs, SPI. J. Pharmacol. Exp. Ther. 288(3), 1117-1124 (1999).

    3. Oslund, R.C., Cermak, N., and Gelb, M.H. Highly specific and broadly potent inhibitors of mammalian secreted phospholipases A2. J. Med. Chem. 51(15), 4708-4714 (2008).

    4. Smart, B.P., Pan, Y.H., Weeks, A.K., et alInhibition of the complete set of mammalian secreted phospholipases A2 by indole analogues: A structure-guided study. Bioorg. Med. Chem. 12(7), 1737-1749 (2004).